Preliminary Sales Figures for Q4 (+22%) and FY 2005 (+15%)

aap Implantate AG, a German medical technology company specialized in healing frac-tures, joint replacement, bone cements and biomaterials, reports preliminary sales of EUR 3.6 million in the fourth quarter of 2005 – a 22% year-on-year increase (previous year: EUR 3.0 million).

In the full financial year 2005 the Group’s preliminary sales totaled EUR 13.3 million and were therefore 15% up on the previous year’s EUR 11.5 million. ADC and Osartis, com-panies acquired as of October 1, 2005 and since fully consolidated, posted combined sales of around EUR 0.2 million to the total revenues. Without these contributions Group’s organic growth would be 13.2%. Sales growth was mainly in biomaterials and bone cements.

aap anticipates further significant sales growth in the year ahead.

aap Implantate AG’s full financial statements for 2005 will be published on March 31, 2006.